-
1 Comment
ReWalk Robotics Ltd is currently in a long term downtrend where the price is trading 18.7% below its 200 day moving average.
From a valuation standpoint, the stock is 99.4% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 8.1.
ReWalk Robotics Ltd's total revenue rose by 3.1% to $1M since the same quarter in the previous year.
Its net income has increased by 17.6% to $-3M since the same quarter in the previous year.
Finally, its free cash flow grew by 31.8% to $-2M since the same quarter in the previous year.
Based on the above factors, ReWalk Robotics Ltd gets an overall score of 4/5.
CurrencyCode | USD |
---|---|
Exchange | NASDAQ |
Industry | Medical Devices |
Sector | Healthcare |
ISIN | IL0011331076 |
Dividend Yield | 0.0% |
---|---|
Market Cap | 39M |
Beta | 2.48 |
Target Price | 3 |
PE Ratio | None |
ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes robotic exoskeletons for individuals with mobility impairments or other medical conditions in the United States, Europe, the Asia-Pacific, and Africa. The company offers ReWalk Personal and ReWalk Rehabilitation for spinal cord injuries and everyday use by paraplegic individuals at home and in communities; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke in the clinical rehabilitation environment; and MyoCycle and MediTouch tutor movement biofeedback devices for use at home or in clinic. It markets and sells its products directly to third party payers; institutions, including rehabilitation centers; and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was incorporated in 2001 and is headquartered in Yokneam Ilit, Israel.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for RWLK using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2024